1. Home
  2. VTSI vs MCRB Comparison

VTSI vs MCRB Comparison

Compare VTSI & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$3.00

Market Cap

51.0M

ML Signal

HOLD

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$5.29

Market Cap

47.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTSI
MCRB
Founded
1993
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.0M
47.4M
IPO Year
1999
2015

Fundamental Metrics

Financial Performance
Metric
VTSI
MCRB
Price
$3.00
$5.29
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$5.00
$14.00
AVG Volume (30 Days)
34.6K
58.5K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$185,971.00
$789,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$27.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.88
$4.32
52 Week High
$6.29
$29.98

Technical Indicators

Market Signals
Indicator
VTSI
MCRB
Relative Strength Index (RSI) 43.82 54.38
Support Level $2.98 $4.59
Resistance Level $3.59 $5.65
Average True Range (ATR) 0.16 0.26
MACD -0.01 0.12
Stochastic Oscillator 6.51 98.02

Price Performance

Historical Comparison
VTSI
MCRB

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of judgmental use-of-force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company operates in six segments, which include Simulators and Accessories, Extended Service, Customized software and Custom content, Installation and Training, Design and Prototyping, and Subscription Training Equipment Partnership. The majority of its revenue is generated from the Simulators and Accessories segment.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Share on Social Networks: